Position in BEAM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$46,332,000
+$14,161,500 QoQ
Shares Held
1,350,000
0.0% QoQ
Ownership
1.31%
of shares outstanding
% of Portfolio
2.32%
of 13F equity value
Holder Rank
#19
of 274 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BEAM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Casdin Capital, LLC holds $1,258,350,419 across 31 Biotechnology names. BEAM ranks #6 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,577,333 | $482,682,924 | |
| 2 | RLAY |
Relay Therapeutics, Inc.
|
16,035,240 | $300,019,340 | |
| 3 | GPCR |
Structure Therapeutics Inc.
|
1,175,000 | $63,062,250 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
2,045,000 | $52,597,400 | |
| 5 | NGNE |
Neurogene Inc.
|
1,545,361 | $48,601,603 | |
| 6 | BEAM |
Beam Therapeutics Inc.
This page
|
1,350,000 | $46,332,000 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
665,000 | $36,575,000 | |
| 8 | MAZE |
Maze Therapeutics, Inc.
|
843,857 | $25,180,692 |
All Filings in BEAM
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,332,000 | 1,350,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $32,170,500 | 1,350,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $44,352,000 | 1,600,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $38,832,000 | 1,600,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $24,664,500 | 1,450,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $27,841,225 | 1,425,562 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $31,000,000 | 1,250,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $18,987,500 | 775,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $15,815,250 | 675,000 | Shares | Sole | 2024-10-18 | |
| 2024-03-31 | $22,302,000 | 675,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $14,372,160 | 528,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $13,708,500 | 570,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $18,200,100 | 570,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $17,453,400 | 570,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $14,470,700 | 370,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $17,626,800 | 370,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $14,516,250 | 375,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $46,918,386 | 818,820 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $65,251,765 | 818,820 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $71,245,528 | 818,820 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $105,390,322 | 818,820 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $65,538,352 | 818,820 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $37,554,400 | 460,000 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||